2Dahl R, Greefhorst A, Nowak D, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001,164(5) :778 - 784.
3Rossi A, Kristufek P, Levine B E, et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD[J].Chest, 2002,121(4) : 1058 - 1069.
4Van Noord J, De Munck D, Bantje T, et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium [ J ]. Eur Respir J, 2000,15(5) :878 - 885.
5Sichletidis L, Kottalds J, Marcou S, et al. Bronchodilatory responses to formoterol,ipratropium, and their combination in patients with stable COPD[J]. Int J Clin Pract, 1999,53(3):185- 188.
6ZuWallack R L, Mahler D A, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD[J].Chest, 2001,119(6) : 1661 - 1670.
7D' Urzo A D, De Salvo M C, Bamirez-Rivera A, et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, doulde-blind, within-patient, multicenter study[J]. Chest, 2001,119(5) : 1347 - 1356.
8Celik G, Kayacan O, Bedex S, et al. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: a crossover, placebo-controlled compaison of onsetand duration of action[J]. Respiration, 1999,66(5):434-439.
9Cazzola M, D'Amato M, Califano C, et al. Formoterol as dry powder oral inbalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease [J].Clin Ther, 2002,24(4):595-604.
10Noord J A V, Bantje T A, Eland M E, et al. A randomized controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease [ J l.Thorax, 2000,55(4) :289-294.
